Compare two different methods of ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome

Compare the effectiveness of two different methods of ultrasound-guided local corticosteroid injection in the treatment of patient with carpal tunnel syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015101724572N1

Enrollment

Registered

2016-05-25

Start date

2016-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: In the first group,corticosteroid inject under the ultrasound-guid above the median nerve which will be done by an experienced physical medicine and rehabilitation specialist using in-

Treatment - Other

In the first group,corticosteroid inject under the ultrasound-guid above the median nerve which will be done by an experienced physical medicine and rehabilitation specialist using in-plane approach.

In the other group, corticosteroid injection will be performed under the ultrasound-guid below the median nerve which will be done by an experienced physical medicine and rehabilitation specialist usi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with signs and symptoms of carpal tunnel syndrome (including pain and sensory disturbances in the territory of median nerve) which is confirmed through EMG-NCS and by electrodiagnostic criteria are mild to moderate carpal tunnel syndromes. Exclusion criteria: severe carpal tunnel syndrome in EMG-NCV; tenar atrophy; contraindications for corticosteroid injection (including sensitivity to corticosteroids and symptoms of skin infection at the injection site); diseases which mimic CTS symptoms such as polyneuropathy, cervical radiculopathy, thoracic outlet syndrome; surgery or local injection treatments in last six months; neoplastic or traumatic source of pain; wrist bones fracture.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The severity of symptoms and functional limitations. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Boston questionnare.;The severity of symptoms. Timepoint: Zero, six and twelve weeks after. Method of measurement: Visual Analog Scale(VAS).;Electrodiagnostic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using EMG-NCV device.;Sonographic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Sonographic device.	—

Measure

Time frame

The severity of symptoms and functional limitations. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Boston questionnare.;The severity of symptoms. Timepoint: Zero, six and twelve weeks after. Method of measurement: Visual Analog Scale(VAS).;Electrodiagnostic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using EMG-NCV device.;Sonographic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Sonographic device.

—

Secondary

Measure	Time frame
Side effects. Timepoint: Six and twelve weeks after. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026